Population Pharmacokinetics¶
U.S. Food and Drug Administration. (2022). Population Pharmacokinetics.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Mechanisms¶
- Population PK/PD Covariate Model
- That a-priori individualization is available on day one, before a single blood test, precisely because the population model separated the explainable spread from the noise.
This sourceExplains that population pharmacokinetic models separate covariate-explained interindividual variability from residual variability and can inform individualized dosing before individual concentration measurements are available.
- That a-priori individualization is available on day one, before a single blood test, precisely because the population model separated the explainable spread from the noise.
Verification¶
Does it exist? Not checked yet. This entry carries no identifier to resolve. It was extracted from the citation as written in the article, normalized, and deduplicated against the rest of the registry.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:8ff1f3e4867a · see in the full table